In the Need to Know column on Christmas Eve, Barbara Kollmeyer shared insights from strategists at Evercore ISI led by Julian Emanuel, who considered year-end selling action and corporate financial ...

These are valuable exercises, but a retirement plan with a 10% chance of failure looks a lot better in a spreadsheet than it sounds in real life. The problem is that if it goes wrong, there is no - I ...

Jillian Berman explains what may lie ahead for people in the U.S. with student debt during President-elect Donald Trump's second term in office, and shares practical advice on pitfalls to avoid. Want ...

The latest dispute is over immigration, and whether Trump should side with technology moguls like Tesla (TSLA) CEO Elon Musk, who have argued that the U.S. should be allowing in more immigrants, not ...

President-elect Donald Trump on Friday asked the Supreme Court to put the brakes on a law that would ban or force a sale of TikTok a day before he takes office on Jan. 20, saying he wanted to ...

Developments in the global market, the academic arena, and in Morningstar research.

Major indexes, which had barely budged Thursday, finished higher for the week-and are closing in on strong full-year gains. Heading into a new year with a new administration, policymakers project ...

The stock declined on seven of those occasions, or 78% of them, ranging from edging downward by 1.1% in November 2007 to falling 19.3% in February 1999. The two times it rose it posted gains of around ...

It's seen in our commitment to bringing your whole selves to work and being adaptive and flexible about how and where we work. Individual flexibility and the ability to make choices that support ...

The Institute for Supply Management releases its Chicago Business Barometer for December. Consensus estimate is for a 42.8 reading, 2.6 points more than in November. The National Association of ...

Netflix has certainly done its share to promote the second season: It not only gave it a prime holiday spot on the calendar - it debuted the day after Christmas - but it also has created a free mobile ...

Bristol Myers Squibb received approval from the Food and Drug Administration for its treatment of certain cancers.